Fate Therapeutics, Inc. Competitors

FATE 
$5.08
*  
0.08
1.6%
Get FATE Alerts
*Delayed - data as of Mar. 5, 2015  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / ▼ Low ▼ P / E Ratio Market Cap
Biogen Idec Inc.
BIIB: NASDAQ-GS
$ 425.61 11.48 ▲ 1,846,299 $ 425.70
$ 417.09
$ 417.18
$ 272.02
34.35 100,509,929,550
Amgen Inc.
AMGN: NASDAQ-GS
$ 159.60 0.41 ▲ 2,470,279 $ 161.48
$ 158.857
$ 173.14
$ 108.20
23.82 121,402,932,000
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 101.24 -1.05 ▼ 343,233 $ 106.65
$ 99.755
$ 122.88
$ 60.19
NE 3,729,884,080
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 103.415 0.36 ▲ 8,647,050 $ 104.45
$ 102.7199
$ 116.83
$ 63.50
14.01 156,018,487,560
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 112.23 12.18 ▲ 1,677,070 $ 112.53
$ 101.50
$ 106.23
$ 17.40
NE 3,234,805,290
Bio-Techne Corp
TECH: NASDAQ-GS
$ 97.81 0.27 ▲ 151,478 $ 98.80
$ 97.18
$ 99.154
$ 82.63
31.55 3,626,403,560
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 64.97 1.78 ▲ 853,458 $ 66.26
$ 64.20
$ 89.21
$ 21
NE 2,491,534,530
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 81.80 2.09 ▲ 169,930 $ 82.94
$ 78.51
$ 80.234
$ 31.55
29.96 2,016,942,600
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 57.53 3.00 ▲ 217,443 $ 59.09
$ 54.90
$ 63.63
$ 40.16
NE 1,351,379,700
Avalanche Biotechnologies, Inc.
AAVL: NASDAQ-GM
$ 37.94 1.33 ▲ 358,742 $ 38.2374
$ 35.96
$ 62.48
$ 22
NE 953,166,620
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 52.03 2.03 ▲ 2,210,177 $ 54.42
$ 51.07
$ 61.70
$ 34.71
NE 4,621,512,720
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 35.60 0.48 ▲ 1,437,097 $ 36.585
$ 35.41
$ 55.46
$ 30.05
NE 4,410,555,200
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 41.34 0.33 ▲ 373,841 $ 42.22
$ 41.09
$ 53.93
$ 23.61
NE 1,333,339,020
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 35.30 -0.44 ▼ 471,923 $ 36.83
$ 35.18
$ 45.45
$ 28.26
84.05 1,480,764,400
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 40.92 -0.35 ▼ 1,043,446 $ 42.38
$ 40.83
$ 41.83
$ 12.17
NE 3,110,124,600
Cellular Biomedicine Group, Inc.
CBMG: NASDAQ-CM
$ 32.39 2.89 ▲ 74,700 $ 32.49
$ 29.90
$ 38.99
$ 9
NE 322,150,940
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 28.75 2.20 ▲ 299,403 $ 30.40
$ 25.54
$ 35.45
$ 9.66
NE 581,123,750
Applied Genetic Technologies Corporation
AGTC: NASDAQ-GM
$ 20.95 0.55 ▲ 19,330 $ 21.44
$ 20.40
$ 34.37
$ 11.10
NE 343,810,450
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 29.71 -2.91 ▼ 190,851 $ 33.15
$ 29.26
$ 33.30
$ 12.27
NE 988,095,180
Aerie Pharmaceuticals, Inc.
AERI: NASDAQ-GM
$ 28.92 0.12 ▲ 241,704 $ 29.43
$ 28.76
$ 32.50
$ 13.66
NE 693,617,280
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 21.19 0.03 ▲ 39,551 $ 21.47
$ 21.12
$ 28.50
$ 21.05
NE 781,699,100
Repligen Corporation
RGEN: NASDAQ-GS
$ 25.78 0.67 ▲ 332,090 $ 26.59
$ 24.9909
$ 26.889
$ 12.04
71.61 843,573,160
Qiagen N.V.
QGEN: NASDAQ-GS
$ 25.18 0.39 ▲ 942,122 $ 25.21
$ 24.91
$ 25.32
$ 19.46
51.39 5,875,878,900
Sangamo BioSciences, Inc.
SGMO: NASDAQ-GS
$ 18.06 0.08 ▲ 1,034,083 $ 18.88
$ 17.81
$ 24.69
$ 9.39
NE 1,235,376,240
Genocea Biosciences, Inc.
GNCA: NASDAQ-GM
$ 8.60 0.27 ▲ 18,676 $ 8.73
$ 8.50
$ 23.99
$ 6.15
NE 151,446,000